AstraZeneca (AstraZeneca) Days Payable : 470.66 (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

What is AstraZeneca Days Payable?

AstraZeneca's average Accounts Payable for the three months ended in Dec. 2023 was $11,905 Mil. AstraZeneca's Cost of Goods Sold for the three months ended in Dec. 2023 was $2,308 Mil. Hence, AstraZeneca's Days Payable for the three months ended in Dec. 2023 was 470.66.

The historical rank and industry rank for AstraZeneca's Days Payable or its related term are showing as below:

AZN' s Days Payable Range Over the Past 10 Years
Min: 75.56 Med: 143.48 Max: 579.92
Current: 579.92

During the past 13 years, AstraZeneca's highest Days Payable was 579.92. The lowest was 75.56. And the median was 143.48.

AZN's Days Payable is ranked better than
94.27% of 977 companies
in the Drug Manufacturers industry
Industry Median: 86.23 vs AZN: 579.92

AstraZeneca's Days Payable increased from Dec. 2022 (318.49) to Dec. 2023 (470.66). It may suggest that AstraZeneca delayed paying its suppliers.

AstraZeneca Days Payable Historical Data

The historical data trend for AstraZeneca's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Days Payable Chart

AstraZeneca Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

129.58

142.03

75.92

79.15

128.40

AstraZeneca Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial															318.49	521.15	906.63	877.22	470.66

Competitive Comparison of AstraZeneca's Days Payable

For the Drug Manufacturers - General subindustry, AstraZeneca's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AstraZeneca's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca's Days Payable distribution charts can be found below:

* The bar in red indicates where AstraZeneca's Days Payable falls into.

AstraZeneca Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

AstraZeneca's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (2550	+	3267)	/	2 )	/	8268	*	365
=	2908.5					/	8268	*	365
=	128.40

AstraZeneca's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (20542	+	3267)	/	2 )	/	2308	*	365 / 4
=	11904.5					/	2308	*	365 / 4
=	470.66

AstraZeneca Days Payable Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca (AstraZeneca) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (NAS:AZN) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

AZNCF:USA AZN:Sweden AZNN:Mexico AZNl:UK AZN:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany A1ZN34:Brazil

Address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA

Website

https://www.astrazeneca.com

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.